1. Home
  2. ZDAI vs PDSB Comparison

ZDAI vs PDSB Comparison

Compare ZDAI & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ZDAI

Primega Group Holdings Limited Ordinary Shares

N/A

Current Price

$1.64

Market Cap

13.6M

ML Signal

N/A

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

N/A

Current Price

$0.22

Market Cap

11.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZDAI
PDSB
Founded
2022
2005
Country
Hong Kong
United States
Employees
N/A
10
Industry
General Bldg Contractors - Nonresidential Bldgs
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.6M
11.6M
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
ZDAI
PDSB
Price
$1.64
$0.22
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
47.3K
2.5M
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.20
52 Week High
$11.48
$1.55

Technical Indicators

Market Signals
Indicator
ZDAI
PDSB
Relative Strength Index (RSI) 43.62 22.06
Support Level $1.62 $0.20
Resistance Level $2.04 $0.77
Average True Range (ATR) 0.17 0.06
MACD 0.01 0.00
Stochastic Oscillator 13.00 4.75

Price Performance

Historical Comparison
ZDAI
PDSB

About ZDAI Primega Group Holdings Limited Ordinary Shares

DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

Share on Social Networks: